DUSP22 | Dual specificity phosphatase 22 | Enzymes
| | | | | Expressed in all |
IRF4 | Interferon regulatory factor 4 | Cancer-related genes Disease related genes Transcription factors
| | | | | Mixed |
EXOC2 | Exocyst complex component 2 | RAS pathway related proteins
| | | | | Expressed in all |
FOXQ1 | Forkhead box Q1 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
FOXC1 | Forkhead box C1 | Disease related genes Plasma proteins Transcription factors
| | | | | Tissue enriched |
GMDS | GDP-mannose 4,6-dehydratase | Enzymes
| | | | | Expressed in all |
WRNIP1 | Werner helicase interacting protein 1 | Enzymes Plasma proteins
| | | | | Expressed in all |
SERPINB1 | Serpin peptidase inhibitor, clade B (ovalbumin), member 1 | Plasma proteins
| | | | | Expressed in all |
SERPINB9 | Serpin peptidase inhibitor, clade B (ovalbumin), member 9 | | | | | | Mixed |
SERPINB6 | Serpin peptidase inhibitor, clade B (ovalbumin), member 6 | Disease related genes Plasma proteins
| | | | | Expressed in all |
NQO2 | NAD(P)H dehydrogenase, quinone 2 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
RIPK1 | Receptor (TNFRSF)-interacting serine-threonine kinase 1 | Enzymes
| | | | | Expressed in all |
BPHL | Biphenyl hydrolase-like (serine hydrolase) | | | | | | Expressed in all |
TUBB2A | Tubulin, beta 2A class IIa | | | | | | Tissue enriched |
PRPF4B | Pre-mRNA processing factor 4B | Enzymes Plasma proteins
| | | | | Expressed in all |
ECI2 | Enoyl-CoA delta isomerase 2 | Enzymes
| | | | | Expressed in all |
CDYL | Chromodomain protein, Y-like | Enzymes
| | | | | Expressed in all |
LYRM4 | LYR motif containing 4 | Disease related genes
| | | | | Expressed in all |
F13A1 | Coagulation factor XIII, A1 polypeptide | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
LY86 | Lymphocyte antigen 86 | Predicted secreted proteins
| | | | | Tissue enhanced |
RREB1 | Ras responsive element binding protein 1 | Transcription factors
| | | | | Expressed in all |
SSR1 | Signal sequence receptor, alpha | Predicted membrane proteins
| | | | | Expressed in all |
CAGE1 | Cancer antigen 1 | | | | | | Tissue enriched |
RIOK1 | RIO kinase 1 | Enzymes
| | | | | Expressed in all |
DSP | Desmoplakin | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Group enriched |
SNRNP48 | Small nuclear ribonucleoprotein 48kDa (U11/U12) | | | | | | Expressed in all |
TXNDC5 | Thioredoxin domain containing 5 (endoplasmic reticulum) | Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
SLC35B3 | Solute carrier family 35 (adenosine 3'-phospho 5'-phosphosulfate transporter), member B3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
TFAP2A | Transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) | Disease related genes Transcription factors
| | | | | Tissue enhanced |
C6orf52 | Chromosome 6 open reading frame 52 | | | | | | Tissue enhanced |
PAK1IP1 | PAK1 interacting protein 1 | | | | | | Expressed in all |
SYCP2L | Synaptonemal complex protein 2-like | | | | | | Tissue enhanced |
EDN1 | Endothelin 1 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
PHACTR1 | Phosphatase and actin regulator 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
SIRT5 | Sirtuin 5 | FDA approved drug targets
| | | | | Expressed in all |
NOL7 | Nucleolar protein 7, 27kDa | | | | | | Expressed in all |
RANBP9 | RAN binding protein 9 | | | | | | Expressed in all |
CD83 | CD83 molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
JARID2 | Jumonji, AT rich interactive domain 2 | Plasma proteins Transcription factors
| | | | | Expressed in all |
DTNBP1 | Dystrobrevin binding protein 1 | Disease related genes
| | | | | Expressed in all |
ATXN1 | Ataxin 1 | Disease related genes
| | | | | Expressed in all |
CAP2 | CAP, adenylate cyclase-associated protein, 2 (yeast) | Cancer-related genes
| | | | | Tissue enhanced |
FAM8A1 | Family with sequence similarity 8, member A1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
NUP153 | Nucleoporin 153kDa | | | | | | Expressed in all |
TPMT | Thiopurine S-methyltransferase | Disease related genes Enzymes FDA approved drug targets
| | | | | Expressed in all |
KDM1B | Lysine (K)-specific demethylase 1B | | | | | | Expressed in all |
DEK | DEK oncogene | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
E2F3 | E2F transcription factor 3 | Cancer-related genes Transcription factors
| | | | | Expressed in all |
SOX4 | SRY (sex determining region Y)-box 4 | Transcription factors
| | | | | Expressed in all |
HDGFL1 | Hepatoma derived growth factor-like 1 | | | | | | Tissue enriched |